The FDA is seeking to further understand topics related to evaluating the safety and efficacy of the drug, including results in patients who have taken it… Read More
Eli Lilly’s stock dips as Alzheimer’s drug delayed by surprise FDA panel meeting
2024-03-08T12:01:00-05:00March 8th, 2024|
Related Posts
-
Why Have Stocks Soared Since The April Lows?
May 19th, 2024